Hims & Hers Health Surges to 11th Most Traded Stock with $672.7 Million Turnover Despite 3.59% Price Decline

On June 3, 2025, Hims & Hers Health (HIMS) experienced a significant surge in trading volume, with a turnover of $672.7 million, marking a 225.71% increase from the previous day. This surge placed HIMS as the 11th most traded stock of the day. However, despite the high trading volume, the stock price of HIMS closed the day with a 3.59% decline.

Hims & Hers Health has announced its plans to acquire ZAVA, a European telehealth platform. This strategic acquisition aims to expand the company's presence in the United Kingdom and launch its services in Germany, France, and Ireland. The acquisition is expected to increase Hims & Hers' active customer base by around 50%, adding approximately 1.3 million new customers.

The acquisition of ZAVA is part of Hims & Hers Health's broader strategy to expand its footprint in Europe. The company intends to establish its own brand in these new markets through the Zava platform within the coming quarters. The financial details of the deal have not been disclosed, but Hims & Hers Health plans to fund the acquisition using cash on hand.

Analysts have expressed mixed sentiments regarding the acquisition. While some view it as a positive move that accelerates the company's personalization strategy, others have raised concerns about the cheaper price of weight loss drugs on Zava and the similar offerings available through both platforms. Despite these concerns, the acquisition is expected to significantly boost Hims & Hers Health's customer base and market presence in Europe.